Clinical trials sponsored by Incyte Corporation
5
Recruiting trials
9
Conditions studied
Phase breakdown
Phase 1 2Phase 3 1Not applicable 2
Conditions studied
| Condition | Trials |
|---|---|
| Atopic Dermatitis | 2 |
| Eczema | 2 |
| Pancreatic cancer | 2 |
| Pregnancy Related | 2 |
| Solid Tumors | 2 |
| Chronic kidney disease | 1 |
| Colorectal cancer | 1 |
| Lung cancer | 1 |
| Renal Impairment | 1 |
Recruiting trials led by Incyte Corporation
- A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
- A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
Common questions
How many trials is Incyte Corporation recruiting for?
Incyte Corporation is the lead sponsor of 5 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.